PilVax: A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae
0 sources
PilVax: A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae
Summary
PilVax: A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae is a master's thesis[1].
Key Facts
- PilVax: A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae authored A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae — author (P50): Callum Chalmers[2].
- PilVax: A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae's instance of is recorded as A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae — instance of (P31): master's thesis[3].
- PilVax: A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae's publisher is recorded as A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae — publisher (P123): ResearchSpace@Auckland[4].
- PilVax: A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae's country of origin is recorded as A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae — country of origin (P495): New Zealand[5].
- PilVax: A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae's publication date is recorded as +2018-00-00T00:00:00Z[6].
- PilVax: A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae's main subject is recorded as A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae — main subject (P921): Streptococcus pneumoniae[7].
- PilVax: A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae's main subject is recorded as A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae — main subject (P921): biomedical sciences[8].
- PilVax: A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae's Handle ID is recorded as 2292/37446[9].
- PilVax: A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae's title is recorded as PilVax: A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae[10].
- PilVax: A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae's copyright holder is recorded as A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae — copyright holder (P3931): Callum Chalmers[11].
- PilVax: A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae's thesis submitted to is recorded as A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae — thesis submitted to (P4101): University of Auckland[12].
- PilVax: A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae's on focus list of Wikimedia project is recorded as A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae — on focus list of Wikimedia project (P5008): NZThesisProject[13].
- PilVax: A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae's copyright status is recorded as A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae — copyright status (P6216): copyrighted[14].
- PilVax: A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae's online access status is recorded as A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae — online access status (P6954): closed user group[15].
- PilVax: A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae's thesis committee member is recorded as A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae — thesis committee member (P9161): Thomas Proft[16].
- PilVax: A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae's thesis committee member is recorded as A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae — thesis committee member (P9161): Jacelyn M S Loh[17].
Body
Designation and Status
PilVax: A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae's instance of is recorded as A novel peptide antigen delivery system for the development of an effective vaccine against Streptococcus pneumoniae — instance of (P31): master's thesis[3].